Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

423
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
423
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

580
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
580
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

541
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
541
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

1.0K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.0K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

324
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
324
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

399
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
399

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The diagnostic performance of the YEARS and Pulmonary Embolism Graduated D-dimer algorithms in patients with prior venous thrombosis suspected of pulmonary embolism.

Research and practice in thrombosis and haemostasis·2026
Same author

Patterns of presentation of suspected and confirmed recurrent venous thromboembolism in patients with prior venous thromboembolism.

Research and practice in thrombosis and haemostasis·2026
Same author

Long-term mortality in patients with first-time pulmonary embolism according to the presence of comorbidities at baseline: a nationwide register study.

European journal of internal medicine·2026
Same author

Safety of Prothrombin Complex Concentrate for Emergency Surgery According to the Oral Factor Xa Inhibitor Level.

Thrombosis and haemostasis·2026
Same author

Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.

The New England journal of medicine·2026
Same author

Recent Advances in Thrombosis and Hemostasis-Part XIII.

Seminars in thrombosis and hemostasis·2026

Related Experiment Video

Updated: Mar 1, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.8K

Venous thromboembolism: Past, present and future.

Sam Schulman1, Walter Ageno, Stavros V Konstantinides

  • 1Sam Schulman, MD, PhD, Thrombosis Service, HHS-General Hospital, 237 Barton St E, Hamilton, ON, L8L 2X2, Canada, Tel. : +1 905 5270271, ext 44479, Fax: +1 905 5211551, E-mail schulms@mcmaster.ca.

Thrombosis and Haemostasis
|June 9, 2017
PubMed
Summary

Venous thromboembolism (VTE) management is evolving with new anticoagulants and diagnostic tools. Optimizing treatment duration and reducing bleeding risk are key priorities for improving patient outcomes and safety.

Keywords:
Venous thromboembolismanticoagulantsdeep-vein thrombosisdiagnosisimagingprophylaxispulmonary embolismreperfusiontreatment

More Related Videos

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

16.6K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

18.0K

Related Experiment Videos

Last Updated: Mar 1, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.8K
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

16.6K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

18.0K

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Pharmacology

Background:

  • Venous thromboembolism (VTE) is a significant global health burden, increasing with longer life expectancies.
  • Heparin prophylaxis has been a long-standing treatment for hospitalized patients at risk of VTE.
  • Non-vitamin K antagonist oral anticoagulants (NOACs) are now approved for specific patient groups, marking a shift in VTE management.

Purpose of the Study:

  • To review current advancements in VTE diagnosis and treatment.
  • To highlight the evolving role of NOACs in thromboprophylaxis and anticoagulation.
  • To identify future priorities in VTE management, including bleeding risk reduction and optimal treatment duration.

Main Methods:

  • Review of clinical trials and diagnostic algorithms for VTE.
  • Analysis of the efficacy and safety of NOACs compared to traditional anticoagulants.
  • Discussion of emerging therapeutic targets and management strategies for VTE.

Main Results:

  • Advanced imaging and diagnostic algorithms improve VTE detection accuracy.
  • NOACs simplify VTE management, enhancing safety and outcomes.
  • Clinical investigation is expanding NOACs use into new prophylactic areas.

Conclusions:

  • Accurate pre-test probability assessment remains crucial for avoiding VTE overdiagnosis.
  • Future research should focus on minimizing bleeding risk and determining optimal anticoagulation duration.
  • Implementing evidence-based practices through incentives is vital for guideline adherence in VTE care.